Summary
- Current Price
- As of today, SPRO price is $2.44, down -3.94% on
- Current Price All-Time High
- SPRO price is currently -89.68% below its historical high of $23.64 set on
- Market Cap
- SPRO current market cap is $141M, up +288.75% over the past 365 days
- PE Ratio
- SPRO current PE ratio is 20.50
- Revenue
- SPRO current annual revenue is $59.62M, up +117.62% year-over-year
- Next Earnings
- As of today, the next earnings release for SPRO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Spero Therapeutics, Inc. |
| Ticker | NASDAQ: SPRO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sperotherapeutics.com |
| Employees | 32 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.44 | ||
| Price, 1D Change | -3.94% | |
| $141M | ||
| - | ||
| 20.50 | ||
| -0.13 | ||
| $60M | ||
| Revenue, 1Y Change | +117.62% | |
| $0.15 | ||
| EPS, 1Y Change | +111.44% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.15 | ||
| EPS Estimate | N/A | $0.67 |
| EPS Est. Change | N/A | +361.43% |
| $59.62M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.44 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +63.93% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.20 | -$1.27 | -5.73% | |
| -$0.10 | $0.15 | +245.20% | |
| $0.67 | N/A | +361.43% | |
| $0.76 | N/A | +423.42% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $38.97M | $27.40M | -29.69% | |
| - | $59.62M | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +275.38% | ||
| +31.89% | ||
| +288.75% | ||
| +45.26% | ||
| +117.62% | ||
| +22.73% | ||
| +111.44% | ||
| +111.76% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.44 | ||
| $2.32 | ||
| SMA 200 vs Price | -5.08% | |
| $2.54 | ||
| SMA 50 vs Price | +4.26% | |
| -0.13 | ||
| $0.13 | ||
| 41.22 | ||
| 38.51% | ||
| 251.54% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $59.62M | ||
| $0.15 | ||
| $0.00 | ||
| 0.00% | ||
| -$24.00K | ||
| -0.04% | ||
| $8.57M | ||
| 14.38% | ||
| -$24.00K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 7.59 | ||
| 7.59 | ||
| - | ||
| 5 | ||
| 1.28 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 20.50 | ||
| 2.37 | ||
| 2.39 | ||
| -4,329.57 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $59.02M | ||
| $40.27M | ||
| $68.92M | ||
| $67.29M | ||
| $9.90M | ||
| $8.87M | ||
| $2.90M | ||
| $1.96M | ||
| $693.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $51.05M | ||
| $24.00K | ||
| - | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $261.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.62M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| -$12.62M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Evercore ISI Group | → | |
| HC Wainwright & Co. | → | |
| TD Cowen | → | |
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with SPRO
FAQ
What is the ticker symbol for Spero Therapeutics, Inc.?
The ticker symbol for Spero Therapeutics, Inc. is NASDAQ:SPRO
Does Spero Therapeutics, Inc. pay dividends?
No, Spero Therapeutics, Inc. does not pay dividends
What sector is Spero Therapeutics, Inc. in?
Spero Therapeutics, Inc. is in the Healthcare sector
What industry is Spero Therapeutics, Inc. in?
Spero Therapeutics, Inc. is in the Biotechnology industry
What country is Spero Therapeutics, Inc. based in?
Spero Therapeutics, Inc. is headquartered in United States
When did Spero Therapeutics, Inc. go public?
Spero Therapeutics, Inc. initial public offering (IPO) was on November 2, 2017
Is Spero Therapeutics, Inc. in the S&P 500?
No, Spero Therapeutics, Inc. is not included in the S&P 500 index
Is Spero Therapeutics, Inc. in the NASDAQ 100?
No, Spero Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Spero Therapeutics, Inc. in the Dow Jones?
No, Spero Therapeutics, Inc. is not included in the Dow Jones index
When was Spero Therapeutics, Inc. last earnings report?
Spero Therapeutics, Inc.'s most recent earnings report was on May 13, 2026
When does Spero Therapeutics, Inc. report earnings?
The date for Spero Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- SPRO Official Website sperotherapeutics.com
- SPRO Profile on Yahoo Finance finance.yahoo.com/quote/SPRO
- SPRO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/spro